GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (STU:S2L) » Definitions » Inventories, Raw Materials & Components

Bausch & Lomb (STU:S2L) Inventories, Raw Materials & Components : €250 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb Inventories, Raw Materials & Components?

Bausch & Lomb's inventories, raw materials & components for the quarter that ended in Dec. 2024 was €250 Mil.

Bausch & Lomb's quarterly raw materials declined from Jun. 2024 (€259 Mil) to Sep. 2024 (€256 Mil) and declined from Sep. 2024 (€256 Mil) to Dec. 2024 (€250 Mil).

Bausch & Lomb's annual raw materials increased from Dec. 2022 (€154 Mil) to Dec. 2023 (€239 Mil) and increased from Dec. 2023 (€239 Mil) to Dec. 2024 (€250 Mil).


Bausch & Lomb Inventories, Raw Materials & Components Historical Data

The historical data trend for Bausch & Lomb's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb Inventories, Raw Materials & Components Chart

Bausch & Lomb Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 119.19 130.10 153.87 239.34 250.21

Bausch & Lomb Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 239.34 248.40 259.19 255.88 250.21

Bausch & Lomb Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Bausch & Lomb Business Description

Industry
Traded in Other Exchanges
Address
520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Bausch & Lomb Headlines

No Headlines